Personal information

No personal information available

Activities

Collapse all

Works (9)

Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma

International Journal of Molecular Sciences
2024-02-16 | Journal article
DOI: 10.3390/ijms25042331
Contributors: Mei-Chee Tai; Leonidas E. Bantis; Gargy Parhy; Taketo Kato; Ichidai Tanaka; Chi-Wan Chow; Junya Fujimoto; Carmen Behrens; Tetsunari Hase; Koji Kawaguchi et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with EGFR-mutated non-small-cell lung cancer: a retrospective, multicenter cohort study

Therapeutic Advances in Medical Oncology
2024-01 | Journal article
DOI: 10.1177/17588359241303090
Contributors: Ichidai Tanaka; Kazumi Hori; Junji Koyama; Soei Gen; Masahiro Morise; Yuta Kodama; Akira Matsui; Ayako Miyazawa; Tetsunari Hase; Yoshitaka Hibino et al.
Source: check_circle
Crossref

Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma

Cancers
2022-05-21 | Journal article
DOI: 10.3390/cancers14102543
Contributors: Johannes F. Fahrmann; Ichidai Tanaka; Ehsan Irajizad; Xiangying Mao; Jennifer B. Dennison; Eunice Murage; Julian Casabar; Jeffrey Mayo; Qian Peng; Muge Celiktas et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1–Negative Lung Adenocarcinomas

JNCI: Journal of the National Cancer Institute
2022-02-07 | Journal article
DOI: 10.1093/jnci/djab183
Contributors: Ichidai Tanaka; Delphine Dayde; Mei Chee Tai; Haruki Mori; Luisa M Solis; Satyendra C Tripathi; Johannes F Fahrmann; Nese Unver; Gargy Parhy; Rekha Jain et al.
Source: check_circle
Crossref

Current Immunotherapeutic Strategies Targeting the PD-1/PD-L1 Axis in Non-Small Cell Lung Cancer with Oncogenic Driver Mutations

International Journal of Molecular Sciences
2021-12-27 | Journal article
DOI: 10.3390/ijms23010245
Contributors: Ichidai Tanaka; Masahiro Morise
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Oxytocin receptor is a promising therapeutic target of malignant mesothelioma

Cancer Science
2021-09 | Journal article
DOI: 10.1111/cas.15025
Contributors: Yuta Kodama; Ichidai Tanaka; Tatsuhiro Sato; Kazumi Hori; Soei Gen; Masahiro Morise; Daisuke Matsubara; Mitsuo Sato; Yoshitaka Sekido; Naozumi Hashimoto
Source: check_circle
Crossref

The current issues and future perspective of artificial intelligence for developing new treatment strategy in non-small cell lung cancer: harmonization of molecular cancer biology and artificial intelligence

Cancer Cell International
2021-08-26 | Journal article
DOI: 10.1186/s12935-021-02165-7
Contributors: Ichidai Tanaka; Taiki Furukawa; Masahiro Morise
Source: check_circle
Crossref

Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Cancer Patients With EGFR Mutation

Clinical Lung Cancer
2020-05 | Journal article
DOI: 10.1016/j.cllc.2020.01.011
Contributors: Ichidai Tanaka; Masahiro Morise; Ayako Miyazawa; Yuta Kodama; Yutaro Tamiya; Soei Gen; Akira Matsui; Tetsunari Hase; Naozumi Hashimoto; Mitsuo Sato et al.
Source: check_circle
Crossref

A phase II trial of Ifosfamide combination with recommended supportive therapy for recurrent SCLC in second-line and heavily treated setting

Cancer Chemotherapy and Pharmacology
2018-02 | Journal article
DOI: 10.1007/s00280-017-3497-0
Contributors: Ichidai Tanaka; Kenji Kawada; Masahiro Morise; Tetsunari Hase; Hiroaki Hayashi; Akihiko Sokai; Asuki Fukatsu; Masashi Kondo; Fumio Nomura; Yoshinori Hasegawa
Source: check_circle
Crossref

Peer review (6 reviews for 2 publications/grants)

Review activity for Cancer cell international. (5)
Review activity for PloS one. (1)
How many people are using ORCID?